THROMBATE III is an effective choice1
In clinical studies, THROMBATE III was proven effective for patients with hereditary antithrombin (AT) deficiency and for the treatment and prevention of thromboembolism, including before, during, and after surgery and childbirth.1
AT and pregnancy fact sheet
Up to 70% of pregnant women with hereditary AT deﬁciency who do not receive prophylaxis may experience thromboembolic complications.2,3 Download the AT and pregnancy fact sheet and see how THROMBATE III directly prevents and treats thromboembolism in patients with hereditary AT deficiency during pregnancy, childbirth, and after delivery.
THROMBATE III and surgical procedures fact sheet
Venous thromboembolism impacts thousands of medical and surgical patients each year.1
Download the THROMBATE III and surgical procedures fact sheet to see how an AT replacement therapy like THROMBATE III is a direct approach to managing hereditary AT deficiency in high-risk situations.
THROMBATE III replaces the AT that is missing1
- THROMBATE III helps prevent and treat thromboembolism during surgery in patients with hereditary AT deficiency1
In clinical studies, the most common adverse reactions (≥ 5% of subjects) were dizziness, chest discomfort, nausea, dysgeusia, and pain (cramps).1